Home
Indices
FTSE 100
Risers/Fallers
US Share Prices
Sectors
News
RNS
Watchlist
Portfolio
Login / Register
Close
Company Search
Become a Member
Track your favourite stocks
Create & monitor portfolios
Daily portfolio value
Sign Up
Quickpicks
£
%
Company
Chg
Chg %
Add shares to your
quickpicks to
display them here!
Share Prices
Immupharma Share Price
Immupharma Share News
Immupharma (IMM) Share News
1
2
3
4
5
6
7
8
9
ImmuPharma Says US Sites Open For Lupuzor Phase III Trial Recruitment
7th Dec 2015 09:36
Read More
WINNERS & LOSERS SUMMARY: Housebuilders And Estate Agents Torn Down
4th Nov 2015 10:31
Read More
ImmuPharma Says Lupuzor Trials Set To Start In US This Year
4th Nov 2015 08:56
Read More
ImmuPharma Appoints Non-Executive Chairman As Loss Narrows
30th Sep 2015 09:29
Read More
ImmuPharma Says Chairman And Co-Founder Richard Warr Dies
29th Jul 2015 09:16
Read More
ImmuPharma Secures Financing To Continue Lupuzor Progress (ALLISS)
27th Jul 2015 07:08
Read More
LONDON MORNING BRIEFING: AB Foods Lifted To Buy From Sell By Goldman
29th May 2015 07:28
Read More
AGM, EGM Calendar - Week Ahead
29th May 2015 05:17
Read More
AGM, EGM Calendar - Week Ahead
28th May 2015 16:28
Read More
ImmuPharma Chairman Takes Leave To Deal With Health Issue
6th May 2015 08:11
Read More
Immupharma To Focus On Lupuzor, 2014 Loss Narrows On Trial End
30th Apr 2015 09:37
Read More
Immupharma Says Cancer Therapy Trial Meets Primary Objective
11th Feb 2015 12:18
Read More
UK MIDDAY BRIEFING: Royal Mail Up As It Meets Low Expectations
22nd Jan 2015 12:00
Read More
UK WINNERS & LOSERS: Oxford Instruments Falls On Another Warning
22nd Jan 2015 11:19
Read More
ImmuPharma Shares Up 22% On Simbec-Orion Lupuzor Agreement
22nd Jan 2015 08:32
Read More
UK MIDDAY BRIEFING: GKN A Winner As Earnings Season Hits Full Swing
21st Oct 2014 11:19
Read More
UK WINNERS & LOSERS: ASOS Back In Style Despite Profit Fall
21st Oct 2014 11:00
Read More
ImmuPharma Gets EUR400,000 Grant In France For Urelix Technology
20th Oct 2014 06:59
Read More
ImmuPharma Poised For Phase III Trials Of Lupuzor As Loss As Expected
30th Sep 2014 09:27
Read More
ImmuPharma Forms European Research Team As Part Of Peptides Drive
27th Jun 2014 12:10
Read More
1
2
3
4
5
6
7
8
9
FTSE 100 Latest
Value
10,552.05
Change
110.45